Company news
Glenmark Pharmaceuticals Limited news in 2025
Glenmark Pharmaceuticals Limited's news releases, calls and decks from 2025, newest first.
Press Release Dec 23 2025
December 23, 2025
Glenmark Pharmaceuticals Limited Press Release Dec 23 2025
December 22, 2025
Press Release Dec 16 2025
December 16, 2025
Press Release Dec 11 2025
December 11, 2025
Glenmark Pharmaceuticals Limited Press Release Dec 11 2025
December 10, 2025
Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe
December 1, 2025
Press Release Nov 27 2025
November 27, 2025
Glenmark Pharmaceuticals Limited Press Release Nov 27 2025
November 26, 2025
Press Release Nov 25 2025
November 25, 2025
Glenmark Pharmaceuticals Limited Press Release Nov 25 2025
November 24, 2025
Q2FY 2025-26
November 19, 2025
Press Release Nov 18 2025
November 18, 2025
Press Release Nov 14 2025
November 14, 2025
Press Release Nov 10 2025
November 10, 2025
Press Release Nov 04 2025
November 4, 2025
Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial
November 4, 2025
Glenmark Pharmaceuticals Limited Press Release Nov 04 2025
November 3, 2025
Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials
October 24, 2025
Press Release Oct 23 2025
October 23, 2025
Glenmark Pharmaceuticals Limited Press Release Oct 23 2025
October 22, 2025
Press Release Sep 24 2025
September 24, 2025
Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811)
September 24, 2025
Press Release Sep 05 2025
September 5, 2025
Press Release Sep 02 2025
September 2, 2025
Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials
September 2, 2025
FY 2024-25
August 29, 2025
Q1FY 2025-26
August 26, 2025
Press Release Aug 19 2025
August 19, 2025
Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial)
August 19, 2025
Press Release Aug 14 2025
August 14, 2025
Press Release Jul 10 2025
July 10, 2025
Glenmark Launches a Transformative Nutrition and Livelihood Project in Emali, Kenya
June 26, 2025
Press Release Jun 24 2025
June 24, 2025
Press Release Jun 09 2025
June 9, 2025
Press Release Jun 02 2025
June 2, 2025
Press Release May 23 2025
May 23, 2025
Press Release May 05 2025
May 5, 2025
Press Release Apr 16 2025
April 16, 2025
Press Release Apr 01 2025
April 1, 2025
Glenmark Pharmaceuticals Limited Press Release Apr 01 2025
March 31, 2025
Press Release Mar 20 2025
March 20, 2025
Press Release Mar 12 2025
March 12, 2025
Press Release Mar 10 2025
March 10, 2025
Glenmark Pharmaceuticals Limited Press Release Mar 10 2025
March 9, 2025
Press Release Mar 03 2025
March 3, 2025
Glenmark Pharmaceuticals Limited Press Release Mar 03 2025
March 2, 2025
Press Release Feb 27 2025
February 27, 2025
Glenmark Pharmaceuticals Limited Press Release Feb 27 2025
February 26, 2025
Press Release Feb 14 2025
February 14, 2025
Glenmark Pharmaceuticals Limited Press Release Feb 14 2025
February 13, 2025
Decks in 2025
- Q2 FY26 Earnings Presentation
Earnings · 18 slides · Nov 14, 2025
- Q1 FY26 Earnings Presentation
Earnings · 13 slides · Aug 14, 2025
- Investor Day (July 2025)
Investor day · 49 slides · Jul 16, 2025
- Investor Day (July 2025)
Investor day · 50 slides · Jul 16, 2025
- Q4 FY25 Earnings Presentation
Earnings · 18 slides · May 23, 2025
- Q4 FY25 Earnings Presentation
Earnings · 19 slides · May 23, 2025
- Q3 FY2025 Earnings Presentation
Earnings · 16 slides · Feb 14, 2025
- Q3 FY25 Earnings Presentation
Earnings · 17 slides · Feb 14, 2025